article

Skip to content The CRC Digest ◆ TRIAL DATA Long-term results show benefit of chemotherapy after liver metastasis surgery — Journal of Clinical Oncology The JCOG0603 trial compared hepatectomy (liver surgery) followed by mFOLFOX6 chemotherapy versus hepatectomy alone for patients with liver metastases from colorectal cancer. This phase II/III randomized trial

Skip to content The CRC Digest ◆ TRIAL DATA Adding immunotherapy to intensive chemotherapy shows promise in hard-to-treat colorectal cancer — Nature Communications The phase II NIVACOR trial tested nivolumab (an immunotherapy drug) combined with FOLFOXIRI/bevacizumab chemotherapy as first-line treatment in patients with RAS or BRAF-mutated metastatic colorectal cancer. These mutations